Opdivo (nivolumab) - Ono Pharmaceutical, BMS
alextatug (ATRC-101) - Atreca
Keytruda (pembrolizumab) - Merck (MSD)
https://jitc.bmj.com/content/10/Suppl_2/A749
 
Bartosz Chmielowski 1; John Weroha 2; Susanna Ulahannan 3; John Powderly 4; Frances Valdes-Albini 5; Tanios Bekaii-Saab 6; Deborah Doroshow 7; Alejandro Recio-Boiles 8; Jordan Berlin 9; Yan Xing 10; Sudha Khurana 11; Jonathan Benjamin 11; Steven Isakoff 12; Benjamin Weinberg 13
 
Oct 6, 2022
 
Prev Next